UNSPSC 51162304: Acetaminophen/brompheniramine/pseudoephedrine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE599. This VA Drug Class (RE599) classifies this compound as belonging to the group COLD REMEDIES, OTHER.

The first component of this combination drug is an analgesic and antipyretic with the molecular formula C8H9NO2, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 362O9ITL9D, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears U.S. National Institutes of Health Compound Identifier 1983. Acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate.

UNSPSC 51162304 Acetaminophen/brompheniramine/pseudoephedrine is a Commodity code that in practice captures state and local procurement of generic multi-source pharmaceuticals and over-the-counter products distributed across government health facilities, community health programs, and emergency-response initiatives. The code sees activity from county health departments, state purchasing consortia, and regional cooperative purchasing alliances that aggregate demand across participating jurisdictions. Recent solicitations reflect two distinct procurement patterns: emergency-response and harm-reduction products (naloxone and drug deactivation systems) procured by county health authorities, and broader generic pharmaceutical and OTC product frameworks established by multistate cooperative purchasing vehicles to serve distributed networks of state agencies and subordinate health facilities.

Recent activity centers on the Upper Midwest and Southeast. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued an RFP in January 2026 (due March 26, 2026) to establish multiple contracts for generic multi-source pharmaceuticals and OTC products for participating state and local government facilities across Minnesota and Oregon, with awarded vendors effective July 1, 2026 and a two-year initial contract term. Separately, Seminole County, Florida posted IFB 60459723LAS on June 30, 2026 (due July 26, 2023) seeking annual procurement of 1,900 units of naloxone and 800 safe drug deactivation systems with quarterly deliveries to the Seminole County Community Health Building. Both solicitations require vendors to demonstrate cGMP and Drug Supply Chain Security Act compliance, maintain specified insurance coverage, and submit detailed product and pricing documentation; the MMCAP RFP weights price competitiveness at 75 percent and requires participation through authorized wholesalers (AmerisourceBergen/Cencora, Cardinal Health, Morris & Dickson), while the county IFB awards on a fixed-fee basis with a two-year initial term and one-year renewal option.